NG-MAST
|
Minimum inhibitory concentration
|
penAalteration
|
mtrRalteration
|
PorB1b (penBalteration)
|
---|
|
Cefixime
|
Ceftriaxone
|
A501 alteration (penAallele [[16]])
|
A-deletion in promoter region
|
MtrR coding region
|
G101
|
A102
|
---|
ST4787 (n = 1)
|
0.25
|
0.25
|
T (XVIII)
|
Yes
|
A39T
|
K
|
D
|
ST4787 (n = 2)
|
0.125
|
0.25
|
T (XVIII)
|
Yes
|
A39T
|
K
|
D
|
ST4787 (n = 1)
|
0.125
|
0.125
|
V (A501 New**)
|
Yes
|
H105Y
|
K
|
D
|
ST4787 (n = 3)
|
0.064
|
0.125
|
T (XVIII)
|
Yes
|
A39T
|
K
|
D
|
ST4787 (n = 1)
|
0.032
|
0.125
|
T (XVIII)
|
Yes
|
A39T
|
K
|
D
|
ST7159 (n = 2)
|
0.064
|
0.125/0.25
|
T (XVIII)
|
Yes
|
D79N T86A H105Y
|
K
|
D
|
ST4676 (n = 1)
|
0.125
|
0.25
|
T (XVIII)
|
Yes
|
H105Y
|
K
|
G
|
3 STsa (n = 4)
|
0.125
|
0.125
|
T (XVIII)
|
Yes
|
A39T
|
K/Db
|
D/Gb
|
12 STs (n = 15)
|
0.064
|
0.125
|
T/V/WTc
|
Yes
|
A39T G45D H105Yd
|
K/D/Te
|
D/G/WTe
|
- NG-MAST, Neisseria gonorrhoeae multiantigen sequence typing; ST, sequence type.
-
a ST7739 (n = 2), ST7160 (n = 1) and ST7741 (n = 1).
-
b G101D/A102G (n = 2) and G101K/A102D (n = 1).
-
c A501V New** (n = 9), XVIII (n = 3), XIII (n = 2) and XII (n = 1).
-
d H105Y (n = 8), A39T (n = 4), and G45D (n = 3).
-
e G101K/A102D (n = 11), G101D/A102G (n = 2), G101D/WT (n = 1), G101T/A102D (n = 1).